Why is XtalPi stock rallying today?

XtalPi Holdings' stock surged by 5.8% to HK$8.49 on Monday following an announcement from its Chairman, Executive Director, and Co-founder, Wen Shuhao. The executive revealed plans to purchase company shares through the open market, with a total target of HK$32 million, all funded from his personal resources. The purchases are expected to be completed before the end of October 2026.

Wen's intentions were driven by his confidence in the group's future prospects and recognition of the company's long-term investment value, a statement that markets interpreted as a strong endorsement from the company's most senior insider. The positive sentiment was further amplified by news that a peer company's subsidiary had entered into a drug discovery collaboration with Stanford University, utilizing small-molecule drug discovery platforms alongside academic disease biology expertise.

This development reinforced investor enthusiasm for the AI-driven drug discovery sector, in which XtalPi operates. The broader market provided a mildly supportive backdrop, with the Hang Seng Index trading in the 24,750–24,860 range during the session.